Results 21 to 30 of about 268,028 (214)

P(VDF-TrFE)/BaTiO3 nanoparticle composite films mediate piezoelectric stimulation and promote differentiation of SH-SY5Y neuroblastoma cells [PDF]

open access: yesAdvanced Healthcare Materials, 5(14): 1808-1820 (2016), 2022
Poly(vinylidene fluoride-trifluoroethylene, P(VDF-TrFE)) and P(VDF-TrFE)/barium titanate nanoparticle (BTNP) films are prepared and tested as substrates for neuronal stimulation through direct piezoelectric effect. Films are characterized in terms of surface, mechanical, and piezoelectric features before in vitro testing on SH-SY5Y cells. In particular,
arxiv   +1 more source

Molecular targeting therapies for neuroblastoma: Progress and challenges

open access: yesMedicinal research reviews (Print), 2020
There is an urgent need to identify novel therapies for childhood cancers. Neuroblastoma is the most common pediatric solid tumor, and accounts for ~15% of childhood cancer‐related mortality.
Atif Zafar   +8 more
semanticscholar   +1 more source

Generalized inverse-Gaussian frailty models with application to TARGET neuroblastoma data [PDF]

open access: yesAnnals of the Institute of Statistical Mathematics (2021), 2020
A new class of survival frailty models based on the Generalized Inverse-Gaussian (GIG) distributions is proposed. We show that the GIG frailty models are flexible and mathematically convenient like the popular gamma frailty model. Furthermore, our proposed class is robust and does not present some computational issues experienced by the gamma model. By
arxiv   +1 more source

Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell

open access: yesScience Advances, 2021
Comparisons of neuroblastoma cells and relevant normal adrenal cells reveal a uniform cell state that characterizes neuroblastoma. Neuroblastoma is a childhood cancer that resembles developmental stages of the neural crest.
Gerda Kildisiute   +38 more
semanticscholar   +1 more source

Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression. [PDF]

open access: yes, 2016
BackgroundNovel therapies are needed for children with high-risk and relapsed neuroblastoma. We hypothesized that MAPK/ERK kinase (MEK) inhibition with the novel MEK1/2 inhibitor binimetinib would be effective in neuroblastoma preclinical models ...
Liu, Yin   +4 more
core   +2 more sources

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome

open access: yesNature Communications, 2021
Telomere maintenance by telomerase activation or alternative lengthening of telomeres (ALT) is a major determinant of poor outcome in neuroblastoma. Here, we screen for ALT in primary and relapsed neuroblastomas (n = 760) and characterize its features ...
S. Hartlieb   +29 more
semanticscholar   +1 more source

Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells [PDF]

open access: yes, 2009
BACKGROUND: Chemoresistance acquisition may influence cancer cell biology. Here, bioinformatics analysis of gene expression data was used to identify chemoresistance-associated changes in neuroblastoma biology.
Barth, Susanne   +10 more
core   +6 more sources

RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children

open access: yesBMC Cancer, 2023
Background Neuroblastoma, a neuroendocrine tumor originating from the sympathetic ganglia, is one of the most common malignancies in childhood. RTEL1 is critical in many fundamental cellular processes, such as DNA replication, DNA damage repair, genomic ...
Ting Zhang   +5 more
doaj   +1 more source

Targeting tachykinin receptors in neuroblastoma [PDF]

open access: yes, 2016
Neuroblastoma is the most common extracranial tumor in children. Despite aggressive multimodal treatment, high-risk neuroblastoma remains a clinical challenge with survival rates below 50%.
Althoff, Kristina   +14 more
core   +3 more sources

Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours

open access: yesBMC Cancer, 2019
Background Neuroblastoma (NB) is a paediatric tumour of the sympathetic nervous system. Half of all cases are defined high-risk with an overall survival less than 40% at 5 years from diagnosis.
P. Fusco   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy